NEW SOLUTIONS Financing solutions emerging from the market: A FoCUS survey and analysis How are market leaders responding to the barriers of cost and uncertainty associated with cell and gene therapies … Read More
Precision Reimbursement for Precision Medicine: Using Real-World Evidence to Evolve From Trial-and-Project to Track-and-Pay to Learn-and-Predict
Basic scientists and drug developers are accelerating innovations toward the goal of precision medicine. Regulators create pathways for timely patient access to precision medicines, including individualized therapies. Healthcare payors acknowledge … Read More
The NEWDIGS Initiative at MIT welcomes Flatiron Health as a new collaborator for the LEAPS Project
CAMBRIDGE, MA October 29, 2021 – Flatiron Health®, a world leader in transforming patients’ real-life experiences into knowledge to help accelerate improvements in cancer care and treatments, has joined the Massachusetts Institute … Read More
Precision for Whom? Partnering with patients to ensure that Precision Medicine targets what matters
Despite decades of growth and adaptation in patient engagement, knowing or being able to find guidance for whichmodel or approach will be most impactful in which healthcare or research context … Read More
FoCUS Monthly Recap: September 2021
NEW RESOURCES Self-Insured Employers Workshop shares practical advice for covering cell and gene therapies In June FoCUS hosted a workshop for self-insured employers to help them understand the challenges and … Read More
LEAPS Monthly Recap: September 2021
NEW RESEARCH Precision for whom? Partnering with patients to ensure that Precision Medicine targets what matters Despite decades of growth and adaptation in patient engagement, knowing or being able to … Read More
Self-Insured Employers Workshop shares practical advice for covering cell and gene therapies
In June FoCUS hosted a workshop for self-insured employers to help them understand the challenges and potential solutions presented by new cell and gene therapies. In our event archive you … Read More
NEWDIGS + National Pharmaceutical Council in Health Affairs: Medicaid Best Price Volatility Could Inhibit Payment Innovation
Value-based payment (VBP) arrangements (also known as outcomes- or performance-based contracting) for drugs transform drug pricing from paying for expected benefits projected from clinical trials to paying for actual benefits … Read More
Upcoming book highlighting NEWDIGS Design Labs now available for pre-order
The LEAPS Project of the MIT NEWDIGS initiative is actively soliciting Use Cases for our workstream focused on methods innovation associated with “Integrating Evidence Using Meta-Analytic Approaches.” This methodology is … Read More
LEAPS seeking nominations for Predictive Outcomes Platform use case
The LEAPS Project of the MIT NEWDIGS initiative is actively soliciting Use Cases for our workstream focused on methods innovation associated with “Integrating Evidence Using Meta-Analytic Approaches.” This methodology is … Read More